CONATUS PHARMACEUTICALS INC - COM (CNAT)

CUSIP: 20600T108

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
4,454,398
Share change
+290,139
Total reported value
$23,475,000
Put/Call ratio
55%
Price per share
$5.27
Number of holders
41
Value change
+$2,670,603
Number of buys
22
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 20600T108?
CUSIP 20600T108 identifies CNAT - CONATUS PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONATUS PHARMACEUTICALS INC - COM (CNAT) as of Q4 2016

As of 31 Dec 2016, CONATUS PHARMACEUTICALS INC - COM (CNAT) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,454,398 shares. The largest 10 holders included MPM ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, AXA, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, KCG HOLDINGS, INC., BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, and COURAGE CAPITAL MANAGEMENT LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.